Regeneron Pharmaceuticals, Inc. (REGN)
753.17
-9.64
(-1.26%)
USD |
NASDAQ |
Oct 13, 16:00
753.17
0.00 (0.00%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Return Price : 753.17 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 12, 2026 | 762.81 |
| October 09, 2026 | 746.54 |
| October 08, 2026 | 739.57 |
| October 07, 2026 | 742.12 |
| October 06, 2026 | 738.72 |
| October 05, 2026 | 726.47 |
| October 02, 2026 | 735.20 |
| October 01, 2026 | 734.81 |
| September 30, 2026 | 758.27 |
| September 29, 2026 | 750.51 |
| September 28, 2026 | 752.25 |
| September 25, 2026 | 788.04 |
| September 24, 2026 | 796.02 |
| September 23, 2026 | 801.82 |
| September 22, 2026 | 803.90 |
| September 21, 2026 | 798.17 |
| September 18, 2026 | 784.85 |
| September 17, 2026 | 789.45 |
| September 16, 2026 | 774.61 |
| September 15, 2026 | 774.11 |
| September 14, 2026 | 793.74 |
| September 11, 2026 | 781.49 |
| September 10, 2026 | 793.26 |
| September 09, 2026 | 807.65 |
| September 08, 2026 | 810.31 |
| Date | Value |
|---|---|
| September 04, 2026 | 827.72 |
| September 03, 2026 | 843.47 |
| September 02, 2026 | 852.03 |
| September 01, 2026 | 823.82 |
| August 31, 2026 | 799.08 |
| August 28, 2026 | 794.19 |
| August 27, 2026 | 807.71 |
| August 26, 2026 | 814.79 |
| August 25, 2026 | 833.56 |
| August 24, 2026 | 828.50 |
| August 21, 2026 | 834.04 |
| August 20, 2026 | 826.64 |
| August 19, 2026 | 840.84 |
| August 18, 2026 | 810.24 |
| August 17, 2026 | 804.99 |
| August 14, 2026 | 802.54 |
| August 13, 2026 | 805.03 |
| August 12, 2026 | 797.06 |
| August 11, 2026 | 796.07 |
| August 10, 2026 | 807.11 |
| August 07, 2026 | 783.45 |
| August 06, 2026 | 771.21 |
| August 05, 2026 | 767.68 |
| August 04, 2026 | 759.77 |
| August 03, 2026 | 758.35 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Incyte Corp. | 108.57 |
| Amgen, Inc. | 412.79 |
| Vertex Pharmaceuticals, Inc. | 485.22 |
| Alnylam Pharmaceuticals, Inc. | 223.76 |
| Gilead Sciences, Inc. | 147.88 |